Ireland
--:--IST
Recruiting Observational

Prospective Registry Of Therapeutic EndoscopiC ulTrasound

NCT04813055 · tracked via the Priya Life Science Italy tracker
Sponsor
Paolo Giorgio Arcidiacono, MD
Phase
Observational
Started
2020-12-01
Last updated
2026-04-13

Condition(s) studied

Gastric Outlet ObstructionBiliary ObstructionAcute Pancreatic Fluid CollectionAcute Pancreatitis With Infected NecrosisAcute CholecystitisChronic Pancreatitis

Investigational drug(s) / intervention(s)

Therapeutic EUSPercutaneous ProceduresSurgical Interventionsnon-EUS-based endoscopic procedures

Therapeutic EUS: 1. EUS-guided collection drainage (transgastric or transduodenal, performed by Lumen Apposing Metal Stents or double pigtail stents) and eventual endoscopic necrosectomy 2. EUS-guided biliary drainage (either of the extrahepatic or intrahepatic biliary tree / transduodenal or transgastric / either as access for subsequent rendez-vous or transpapillary stenting OR for transparietal stenting by metal or plastic stents). 3. EUS-guided gallbladder drainage via Lumen Apposing Metal Stents and eventual subsequent EUS-based cholecystolithotomy 4. EUS-guided gastro-jejunostomy through Lumen Apposing Metal Stents 5. EUS-directed ERCP in post-surgical anatomy (by gastro-gastrostomy or entero-enterostomy performed through Lumen Apposing Metal Stents) 6. EUS-guided pancreatic duct drainage

Percutaneous Procedures: Procedures involving a percutaneous access to a target region (fluid collection, gallbladder, biliary tree)

Surgical Interventions: Surgical interventions to obtain a drainage (e.g. surgical necrosectomy, pancreatico-gastrostomy) or the bypass of a stricture (hepatico-jejunostomy or gastro-jejunostomy)

non-EUS-based endoscopic procedures: Other endoscopic procedures not involving EUS (ERCP with stenting; enteral stenting, Enteroscopy-assisted ERCP)

Study summary

This registry aims to analyze long-term outcomes of therapeutic EUS (T-EUS) procedures, as well as to describe clinical and technical variables potentially predicting clinical success or adverse events, for a better selection of ideal candidates.

The study also includes standard alternatives to T-EUS procedures for outcomes comparison.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * subjects candidate to therapeutic EUS (T-EUS) procedures for any underlying disease * subject eligible to T-EUS procedures but undergoing other non-EUS based endoscopic procedures, percutaneous or surgical procedures * 18 years old or older * able to provide an informed consent to inclusion. Exclusion Criteria: * age \< 18 years * inability or unwillingness to sign the informed consent form (ICF) * contra-indication for endoscopy or use of fluoroscopy

Primary outcome measure(s)

  • Clinical Success — 30 days
    * EUS-guided collection drainage: Resolution or reduction of \> 50% of fluid collections * EUS-guided biliary drainage \[valid also for ERCP with stenting\]: Reduction of \>50% of bilirubin OR management of choledocholithiasis OR resolution of cholangitis * EUS-guided gallbladder drainage: Improvement of clinical symptoms or relief of inflammatory signs/symptoms related to cholecystitis * EUS-guided gastro-jejunostomy \[valid also for enteral stenting\]: Resumption of oral intake (Gastric Outlet Obstruction Scoring System \>/= 2 id est at least semisolid food) * EUS-directed ERCP: Possibility to perform ERCP * EUS-guided pancreatic duct drainage: Relief of abdominal pain and reduction of analgesic drug requirement during follow-up OR reduction in the rate of recurrent pancreatitis.

Trial sites (1)

FacilityCityRegionStatus
IRCCS San Raffaele Scientific Institute Milan Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04813055 on ClinicalTrials.gov ↗ ← All trials in Italy